A novel VCP modulator KUS121 exerts renoprotective effects in ischemia-reperfusion injury with retaining ATP and restoring ERAD-processing capacity
Yusuke HataRyosuke DateDaisuke FujimotoHanako Ohashi IkedaShuro UmemotoTomoko KankiYoshihiko NishiguchiTeruhiko MizumotoManabu HayataYutaka KakizoeYuichiro IzumiAkira KakizukaMasashi MukoyamaTakashige Kuwabara
1
Citation
35
Reference
10
Related Paper
Citation Trend
Abstract:
Acute kidney injury (AKI) is a life-threatening condition and often progresses to chronic kidney disease or the development of other organ dysfunction even after recovery. Despite the increased recognition and high prevalence of AKI worldwide, there has been no established treatment so far. The aim of this study was to investigate the renoprotective effect of Kyoto University substance 121 (KUS121), a novel valosin-containing protein modulator, on AKI. In in vitro experiments, we evaluated cell viability and ATP levels of proximal tubular cells with or without KUS121 under endoplasmic reticulum (ER) stress conditions. In in vivo experiments, the effects of KUS121 were examined in mice with AKI caused by ischemia-reperfusion injury. ER-associated degradation (ERAD)-processing capacity was evaluated by quantification of the ERAD substrate CD3delta-YFP. KUS121 protected proximal tubular cells from cell death under ER stress. The apoptotic response was mitigated as indicated by the suppression of C/EBP homologous protein expression and caspase-3 cleavage, with maintained intracellular ATP levels by KUS121 administration. KUS121 treatment suppressed the elevation of serum creatinine and neutrophil gelatinase-associated lipocalin levels and attenuated renal tubular damage after ischemia-reperfusion. The expression of inflammatory cytokines in the kidney was also suppressed in the KUS121-treated group. Valosin-containing protein expression levels were not altered by KUS121 both in vitro and in vivo. KUS121 treatment restored ERAD-processing capacity associated with potentiation of its upstream pathway, phosphorylated inositol-requiring enzyme-1α, and spliced X box-binding protein-1. In conclusion, these findings indicate that KUS121 can protect renal tubular cells from ER stress-induced injury, suggesting that KUS121 could be a novel and promising therapeutic compound for ischemia-associated AKI.NEW & NOTEWORTHY Novel findings of this study are as follows: 1) Kyoto University substance 121 (KUS121), a novel valosin-containing protein (VCP) modulator, can reduce ATP consumption of VCP; 2) KUS121 reduced endoplasmic reticulum (ER) stress and improved cell viability in proximal tubular cells; 3) KUS121 exerted renoprotective effects against ischemia-reperfusion injury; and 4) KUS121 may prevent ischemic acute kidney injury with ATP retention and restoring ER-associated degradation capacity.Keywords:
Endoplasmic-reticulum-associated protein degradation
Viability assay
Abstract The cellular protein quality control (PQC) system ensures the intracellular misfolded/unfolded proteins to be detected and eliminated. ER-associated degradation (ERAD) and unfolded protein response (UPR) are the key mechanisms of PQC, which maintain protein homeostasis and ensure cell survival. Here, we show that after internalization by human epithelial cells, gold (Au) nanoparticles (NPs) localized in endoplasmic reticulum (ER) and induced an accumulation of misfolded/unfolded proteins. Au NPs activated UPR, but suppressed ERAD shown by a reduced degradation rate of the ERAD marker CD3-δ-YFP, which triggered ER stress through IRE1-XBP1-Chaperones and PERK-eIF2α-ATF4-CHOP pathways. The Au NP-dependent ER stress consequently induced the intracellular accumulation of ROS, and caused cell apoptosis/death, concomitant to production/release of inflammatory cytokines and chemokines. This study for the first time shows that NPs can interfere with the cellular PQC system by impairing ERAD activity, which in turn initiates a cascade of events leading to cell death and inflammation.
Endoplasmic-reticulum-associated protein degradation
XBP1
Proteostasis
Cite
Citations (0)
The endoplasmic reticulum (ER) is a subcellular compartment playing a central role in folding and processing membrane and secretory proteins. The importance of these reactions for normal cellular function is indicated by the fact that blocking of these processes is potentially lethal for cells. Under conditions associated with ER dysfunction, unfolded proteins accumulate in the ER lumen. This is the warning signal of two stress responses: the unfolded protein response (UPR) required for inducing the new synthesis of chaperons to refold the unfolded proteins, and the ER-associated degradation (ERAD) to degrade unfolded proteins at the proteasome. Cells in which UPR and ERAD cannot be activated to such an extent that ER function is restored die by apoptosis. In acute pathological states of the brain, including stroke, neurotrauma and epileptic seizures, and in degenerative diseases ER function is impaired in multiple ways. These include oxidative stress, nitric oxide-induced inactivation of the ER calcium pump resulting in disturbances of ER calcium homeostasis and impairment of UPR and ERAD. Furthermore, proteasomal function is impaired which causes secondary ER dysfunction. The only way to escape this potentially lethal cycle is to induce UPR and thus to activate new synthesis of ER chaperon GRP78 to levels sufficient to refold unfolded proteins. ER dysfunction may induce a state of tolerance, impair cellular functions, or induce apoptosis, depending on the severity and duration and the cell type affected. This review focuses on the possible role of ER dysfunction in the pathological process induced by transient cerebral ischemia. Keywords: endoplasmic reticulum associated degradation, glucose regulated protein, nitric oxide, unfolded protein response
Cite
Citations (62)
Endoplasmic-reticulum-associated protein degradation
Protein Degradation
Cite
Citations (86)
How endoplasmic reticulum (ER) stress leads to cytotoxicity is ill-defined. Previously we showed that HeLa cells readjust homeostasis upon proteostatically driven ER stress, triggered by inducible bulk expression of secretory immunoglobulin M heavy chain (μs) thanks to the unfolded protein response (UPR; Bakunts et al., 2017). Here we show that conditions that prevent that an excess of the ER resident chaperone (and UPR target gene) BiP over µs is restored lead to µs-driven proteotoxicity, i.e. abrogation of HRD1-mediated ER-associated degradation (ERAD), or of the UPR, in particular the ATF6α branch. Such conditions are tolerated instead upon removal of the BiP-sequestering first constant domain (CH1) from µs. Thus, our data define proteostatic ER stress to be a specific consequence of inadequate BiP availability, which both the UPR and ERAD redeem.
Endoplasmic-reticulum-associated protein degradation
ATF6
XBP1
Chaperone (clinical)
Proteotoxicity
Tunicamycin
Cite
Citations (67)
Endoplasmic-reticulum-associated protein degradation
Cite
Citations (603)
Endoplasmic-reticulum-associated protein degradation
ATF6
Protein Degradation
Cite
Citations (110)
Proteins synthesized in the endoplasmic reticulum (ER) are properly folded with the assistance of ER chaperones. Malfolded proteins are disposed of by ER‐associated protein degradation (ERAD). When the amount of unfolded protein exceeds the folding capacity of the ER, human cells activate a defense mechanism called the ER stress response, which induces expression of ER chaperones and ERAD components and transiently attenuates protein synthesis to decrease the burden on the ER. It has been revealed that three independent response pathways separately regulate induction of the expression of chaperones, ERAD components, and translational attenuation. A malfunction of the ER stress response caused by aging, genetic mutations, or environmental factors can result in various diseases such as diabetes, inflammation, and neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, and bipolar disorder, which are collectively known as ‘conformational diseases’. In this review, I will summarize recent progress in this field. Molecules that regulate the ER stress response would be potential candidates for drug targets in various conformational diseases.
Endoplasmic-reticulum-associated protein degradation
Chemical chaperone
Chaperone (clinical)
Cite
Citations (1,046)
Abstract Unfolded protein response (UPR) is a conserved signaling pathway that is activated by accumulation of misfolded proteins in the endoplasmic reticulum (ER) and stimulates production of ER chaperones to restore ER proteostasis. However, little is known how UPR-induced proteins return to their pre-stress levels upon removal of ER stress. TUNICAMYCIN-INDUCED1 (TIN1) is an Arabidopsis protein that is normally expressed in pollen but is rapidly induced by ER stresses in vegetative tissues. Here we show that the ER stress-induced TIN1 is rapidly degraded in the UPR recovery phase. We found that TIN1 degradation depends on its asparagine-linked glycans and requires both EMS-mutagenized bri1 suppressor 5 (EBS5) and EBS6 for its recruitment to the ER-associated degradation (ERAD) complex. Loss-of-function mutations in Arabidopsis ERAD components greatly stabilize TIN1. Interestingly, two other UPR-induced proteins that are coexpressed with TIN1 remained stable upon removal of ER stress, suggesting that rapid degradation during the stress-recovery phase likely applies to a subset of UPR-induced proteins. Further investigation should uncover the mechanisms by which the ERAD machinery differentially recognizes UPR-induced ER proteins.
Endoplasmic-reticulum-associated protein degradation
Tunicamycin
Proteostasis
Protein Degradation
Cite
Citations (2)
Endoplasmic-reticulum-associated protein degradation
Protein Degradation
Cite
Citations (1,946)
Misfolded proteins were formed in the endoplasmic reticulum (ER) due to diverse stresses including metabolic stress and oxidative stress. Accumulation of unfolded proteins in the ER stimulates chaperone expression and ER-associated degradation (ERAD) process. This process involves the recognition of misfolded proteins to maintain the protein quality control, which in turn eliminates in association with the ER membrane. Upregulation of ubiquitination enzymes is an essential mechanism by which ER stress enhances ERAD. Asaronic acid (2,4,5-trimethoxybenzoic acid), identified as one of purple perilla constituents, has anti-diabetic and anti-inflammatory effects. This study attempted to examine whether asaronic acid attenuated the 7Β-hydroxycholesterol-elicited ER stress of macrophages. J774A.1 murine macrophage was incubated with 28 μM 7Β-hydroxycholesterol in absence and presence of 1–20 μΜ asaronic acid up to 24 h. Cytotoxicity was assessed by MTT assay. Expression levels of ER stress-responsive chaperones and ERAD biomarkers were measured by Western blot analysis and immunocytochemical staining with a specific antibody. Asaronic acid at 1–20 μM had a cytoprotective effect on macrophages against 7Β-hydroxycholesterol-induced toxicity. Asaronic acid diminished the induction and activation of ER stress sensors such as Grp/BiP, IRE1, and PERK in macrophages exposed to 7Β-hydroxycholesterol. Also, asaronic acid positively influenced the induction of ERAD process-linked components of EDEM1, OS9, SEl1L, HRD1, and VCP1/p97. Furthermore, asaronic acid promoted subsequent degradation reduced by 7Β-hydroxycholesterol via the cytosolar ubiquitin-proteasome system of macrophages. These results demonstrate that asaronic acid attenuated 7Β-hydroxycholesterol-induced ER stress and improved impaired ER stress-mediated degradation systems. Therefore, asaronic acid may be a potent agent protecting macrophages against pathological ER stress damage. This work was supported by the BK21 FOUR(Fostering Outstanding Universities for Research, 4220200913807) funded by the National Research Foundation of Korea (NRF).
Endoplasmic-reticulum-associated protein degradation
Cite
Citations (0)